Join
Live feed
·
PRReleasevia Quantisnow
Viking Therapeutics Inc. logo

Viking Therapeutics Announces Initiation of VK2735 Oral Maintenance Dosing Clinical Trial in Patients with Obesity

ByQuantisnow·Wall Street's wire, on your screen.
VKTX· Viking Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VKTX (Viking Therapeutics Inc.) and more on Quantisnow.